Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Arlen

Showing results (11-20 of 215) with videos related to

Pageof 22
Sort By:
Oncology (Williston Park, N.Y.)|May 10, 2011
Prostate cancer immunotherapy: the role for sipuleucel-T and other immunologic approachesPhilip M Arlen
Urology|January 30, 2016
Editorial CommentAngela M Arlen
The Journal of Urology|March 11, 2016
Editorial CommentAngela M Arlen
The Journal of Urology|April 16, 2019
Editorial CommentAngela M Arlen
Future Oncology (London, England)|October 5, 2017
Neoantigens in the immuno-oncology spacePhilip M Arlen
Current Urology Reports|February 19, 2017
Dysfunctional Voiders-Medication Versus Urotherapy?Angela M Arlen
Seminars in Surgical Oncology|March 1, 1992
Sarcoma management based on a standardized TNM classificationM Arlen, R Marcove
New York State Journal of Medicine|January 15, 1970
Primary myxosarcoma of legV Pratilas, M Arlen
Journal of Surgical Oncology|October 1, 1993
Monoclonal antibodies and their role in modulation of the immune responseM Arlen, K Y Tsang
Annals of Surgery|March 1, 1974
The extended extrapleural radical mastectomy: its role in the treatment of carcinoma of the breastS F Livingston, M Arlen
Pageof 22

Showing results (11-20 of 215) with videos related to

Sort By:
Pageof 22
Oncology (Williston Park, N.Y.)|May 10, 2011
Prostate cancer immunotherapy: the role for sipuleucel-T and other immunologic approachesPhilip M Arlen
Urology|January 30, 2016
Editorial CommentAngela M Arlen
The Journal of Urology|March 11, 2016
Editorial CommentAngela M Arlen
The Journal of Urology|April 16, 2019
Editorial CommentAngela M Arlen
Future Oncology (London, England)|October 5, 2017
Neoantigens in the immuno-oncology spacePhilip M Arlen
Current Urology Reports|February 19, 2017
Dysfunctional Voiders-Medication Versus Urotherapy?Angela M Arlen
Seminars in Surgical Oncology|March 1, 1992
Sarcoma management based on a standardized TNM classificationM Arlen, R Marcove
New York State Journal of Medicine|January 15, 1970
Primary myxosarcoma of legV Pratilas, M Arlen
Journal of Surgical Oncology|October 1, 1993
Monoclonal antibodies and their role in modulation of the immune responseM Arlen, K Y Tsang
Annals of Surgery|March 1, 1974
The extended extrapleural radical mastectomy: its role in the treatment of carcinoma of the breastS F Livingston, M Arlen
Pageof 22